CD274 and neoplasm: Pharmacologic tumor PDL1 depletion merits additional studies for its clinical ability to target other PDL1 effects, such as mTORC1 signals and rapamycin sensitivity, and for its potential to improve selected ICB as we have demonstrated with chlorambucil.